* AMBIOTIS *
2007 - Midi-Pyrénées
Toulouse
www.ambiotis.com Contract, Services (also, Research, Drugs)
Key words: Validation, Anti-inflammatory, Immunostimulatory, Biomarkers
Mission: to provide preclinical testing services (cellular and animal experiments) for anti-inflammatory and immunostimulatory assays of third parties, and to undertake own research specialized in the study of lipoxins, resolvins and protectins
Clients: Pharmaceutical industry, Cosmetics, Nutraceutics, Agro-food
contact@ambiotis.com
Age: 3 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Dubourdeau (Marc) [founder, born 1973, M.D., Ph.D. Immunology, Ms. Management (Toulouse)]
Sc.Dir.-CSO: Dubourdeau (Marc)
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned (registered capital 2007 = 0.04 M€) | Turnover (M€) : 0.08 (2008)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Inflammation
Position : Subcontractor
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2009 .03 | Company website completed and revamped in 2 languages | INFO | [1 year] |
| 2007 .03 | Company founded by Marc Dubourdeau (initially named as 2iPharma) | ORGF | [0 year] | Actualisation / Updating: 09-Sept-2009 |
|
